Lv1
80 积分 2026-04-14 加入
Canagliflozin Alleviates Metabolic Dysfunction-Associated Steatotic Liver Disease via Mitochondrial Protection and Enhanced Mitophagy
11小时前
待确认
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)
1个月前
已完结
The majority of murine γδ T cells at the maternal–fetal interface in pregnancy produce IL‐17
2个月前
已完结
Metabolic crosstalk: Exploring the dynamic interactions between gut microbiota and metabolism
2个月前
已完结
皖公网安备34019202002308
